{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:57:17Z","timestamp":1787003837324,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"DHAC | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1174145"],"award-info":[{"award-number":["1174145"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031185","name":"Australian Functional Genomics Network","doi-asserted-by":"publisher","award":["11501"],"award-info":[{"award-number":["11501"]}],"id":[{"id":"10.13039\/100031185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009983","name":"UoC | Center for Molecular Medicine Cologne, University of Cologne","doi-asserted-by":"publisher","award":["C18"],"award-info":[{"award-number":["C18"]}],"id":[{"id":"10.13039\/501100009983","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian Functional Genomics Network Clinical and Scientific Review Committees"},{"DOI":"10.13039\/501100025520","name":"DHAC | Medical Research Future Fund","doi-asserted-by":"publisher","award":["MRF2007498"],"award-info":[{"award-number":["MRF2007498"]}],"id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014555","name":"Murdoch Children's Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014555","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Spinal muscular atrophy (SMA) results from\n                    <jats:italic>SMN1<\/jats:italic>\n                    gene loss-of-function (LOF), with disease severity directly linked to the level of remaining SMN protein. Nusinersen, risdiplam, and onasemnogene abeparvovec are revolutionary treatments but should ideally be implemented before clinical symptoms appear. Because of this, prenatal and newborn screenings are increasingly used to identify common\n                    <jats:italic>SMN1<\/jats:italic>\n                    variants and patients requiring therapy. However, for novel variants, clinicians lack robust analytic tools to predict pathogenicity before irreversible damage occurs. To address this gap, we deployed a zebrafish model presenting\n                    <jats:italic>smn1<\/jats:italic>\n                    -LOF, exhibiting progressive motor defects and death by only six days of age. We evaluated two\n                    <jats:italic>SMN1-<\/jats:italic>\n                    variants\u00a0of uncertain significance (VUS) identified in newborn infants awaiting definite diagnosis and treatment recommendations. We demonstrated that while known pathogenic variants did not change the disease course, wild-type\n                    <jats:italic>SMN1<\/jats:italic>\n                    and both infants variants rescued SMA hallmarks in zebrafish, demonstrating the relevance of this approach for VUS-testing within a crucial timeframe for patients. Extending the assay to known\n                    <jats:italic>SMN1<\/jats:italic>\n                    -hypomorphs showed partial rescue, weaker than wild-type or VUS, demonstrating that this approach can also discriminate partial-LOF effects. Both VUS were resolved to be non-pathogenic, and the therapeutic costs of &gt;US$2 million per child were avoided. Beyond SMA, this study provides robust proof-of-principle that the zebrafish represents a powerful translational tool for VUS-analysis, and that such approaches should be considered in clinical settings for supporting diagnosis and treatment decisions.\n                  <\/jats:p>","DOI":"10.1038\/s44321-025-00355-8","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T11:24:15Z","timestamp":1765797855000},"page":"41-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical relevance of zebrafish for gene variants testing. Proof-of-principle with SMN1\/SMA"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4552-9736","authenticated-orcid":false,"given":"Brett W","family":"Stringer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yougang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Taghipour-Sheshdeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1753-5872","authenticated-orcid":false,"given":"Shuxiang","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"K\u00f6lbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4472-0902","authenticated-orcid":false,"given":"Michelle A","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4051-5191","authenticated-orcid":false,"given":"Brunhilde","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2918-4689","authenticated-orcid":false,"given":"Jean","family":"Giacomotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"355_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e14557","volume":"9","author":"M Adhish","year":"2023","unstructured":"Adhish M, Manjubala I (2023) Effectiveness of zebrafish models in understanding human diseases\u2014a review of models. Heliyon 9:e14557","journal-title":"Heliyon"},{"key":"355_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1080\/14737175.2023.2218549","volume":"23","author":"L Balaji","year":"2023","unstructured":"Balaji L, Farrar MA, D\u2019Silva AM, Kariyawasam DS (2023) Decision-making and challenges within the evolving treatment algorithm in spinal muscular atrophy: a clinical perspective. Expert Rev Neurother 23:571\u2013586","journal-title":"Expert Rev Neurother"},{"key":"355_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/bcp.16267","volume":"91","author":"A Belancic","year":"2025","unstructured":"Belancic A, Faour AK, Gkrinia EMM, Vitezic D (2025) A systematic review of economic evaluations of orphan medicines for the management of spinal muscular atrophy. Br J Clin Pharm 91:95\u2013116","journal-title":"Br J Clin Pharm"},{"key":"355_CR4","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1093\/hmg\/ddaa229","volume":"29","author":"AJ Blatnik","year":"2020","unstructured":"Blatnik AJ, McGovern VL, Le TT, Iyer CC, Kaspar BK, Burghes AHM (2020) Conditional deletion of SMN in cell culture identifies functional SMN alleles. Hum Mol Genet 29:3477\u20133492","journal-title":"Hum Mol Genet"},{"key":"355_CR5","doi-asserted-by":"publisher","first-page":"11224","DOI":"10.3390\/ijms241311224","volume":"24","author":"T Bondue","year":"2023","unstructured":"Bondue T, Berlingerio SP, van den Heuvel L, Levtchenko E (2023) The zebrafish embryo as a model organism for testing mRNA-based therapeutics. Int J Mol Sci 24:11224","journal-title":"Int J Mol Sci"},{"key":"355_CR6","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1093\/hmg\/ddp310","volume":"18","author":"KL Boon","year":"2009","unstructured":"Boon KL, Xiao S, McWhorter ML, Donn T, Wolf-Saxon E, Bohnsack MT, Moens CB, Beattie CE (2009) Zebrafish survival motor neuron mutants exhibit presynaptic neuromuscular junction defects. Hum Mol Genet 18:3615\u20133625","journal-title":"Hum Mol Genet"},{"key":"355_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0690-2","volume":"12","author":"SE Brnich","year":"2019","unstructured":"Brnich SE, Abou Tayoun AN, Couch FJ, Cutting GR, Greenblatt MS, Heinen CD, Kanavy DM, Luo X, McNulty SM, Starita LM et al (2019) Recommendations for application of the functional evidence PS3\/BS3 criterion using the ACMG\/AMP sequence variant interpretation framework. Genome Med 12:3","journal-title":"Genome Med"},{"key":"355_CR8","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s10198-022-01548-5","volume":"24","author":"SHS Chan","year":"2023","unstructured":"Chan SHS, Wong CKH, Wu T, Wong W, Yu MKL, Au ICH, Chan GCF (2023) Significant healthcare burden and life cost of spinal muscular atrophy: real-world data. Eur J Health Econ 24:1373\u20131382","journal-title":"Eur J Health Econ"},{"key":"355_CR9","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1093\/brain\/awad061","volume":"146","author":"MA Farrar","year":"2023","unstructured":"Farrar MA, Kiernan MC, Kariyawasam DS (2023) Presymptomatic spinal muscular atrophy: a cautionary approach to the proposed new terminology. Brain 146:e65\u2013e66","journal-title":"Brain"},{"key":"355_CR10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"M Feldkotter","year":"2002","unstructured":"Feldkotter M, Schwarzer V, Wirth R, Wienker TF, Wirth B (2002) Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 70:358\u2013368","journal-title":"Am J Hum Genet"},{"key":"355_CR11","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1002\/dvdy.20995","volume":"235","author":"M Fink","year":"2006","unstructured":"Fink M, Flekna G, Ludwig A, Heimbucher T, Czerny T (2006) Improved translation efficiency of injected mRNA during early embryonic development. Dev Dyn 235:3370\u20133378","journal-title":"Dev Dyn"},{"key":"355_CR12","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1093\/brain\/awac125","volume":"145","author":"RS Finkel","year":"2022","unstructured":"Finkel RS, Benatar M (2022) Pre-symptomatic spinal muscular atrophy: a proposed nosology. Brain 145:2247\u20132249","journal-title":"Brain"},{"key":"355_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8378","volume":"6","author":"J Giacomotto","year":"2015","unstructured":"Giacomotto J, Rinkwitz S, Becker TS (2015) Effective heritable gene knockdown in zebrafish using synthetic microRNAs. Nat Commun 6:7378","journal-title":"Nat Commun"},{"key":"355_CR14","doi-asserted-by":"publisher","first-page":"gkaf004","DOI":"10.1093\/nar\/gkaf004","volume":"53","author":"F Guo","year":"2025","unstructured":"Guo F, Tromp A, Wang H, Hall TE, Giacomotto J (2025) Cre-Lox miRNA-delivery technology optimized for inducible microRNA and gene-silencing studies in zebrafish. Nucleic Acids Res 53:gkaf004","journal-title":"Nucleic Acids Res"},{"key":"355_CR15","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1093\/hmg\/ddt110","volume":"22","author":"T Hao le","year":"2013","unstructured":"Hao le T, Duy PQ, Jontes JD, Wolman M, Granato M, Beattie CE (2013) Temporal requirement for SMN in motoneuron development. Hum Mol Genet 22:2612\u20132625","journal-title":"Hum Mol Genet"},{"key":"355_CR16","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1093\/hmg\/ddy251","volume":"27","author":"CC Iyer","year":"2018","unstructured":"Iyer CC, Corlett KM, Massoni-Laporte A, Duque SI, Madabusi N, Tisdale S, McGovern VL, Le TT, Zaworski PG, Arnold WD et al (2018) Mild SMN missense alleles are only functional in the presence of SMN2 in mammals. Hum Mol Genet 27:3404\u20133416","journal-title":"Hum Mol Genet"},{"key":"355_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S2352-4642(22)00342-X","volume":"7","author":"DS Kariyawasam","year":"2023","unstructured":"Kariyawasam DS, D\u2019Silva AM, Sampaio H, Briggs N, Herbert K, Wiley V, Farrar MA (2023) Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort study. Lancet Child Adolesc Health 7:159\u2013170","journal-title":"Lancet Child Adolesc Health"},{"key":"355_CR18","doi-asserted-by":"publisher","first-page":"100742","DOI":"10.1016\/j.eclinm.2021.100742","volume":"33","author":"DST Kariyawasam","year":"2021","unstructured":"Kariyawasam DST, D\u2019Silva AM, Vetsch J, Wakefield CE, Wiley V, Farrar MA (2021) \u201cWe needed this\u201d: perspectives of parents and healthcare professionals involved in a pilot newborn screening program for spinal muscular atrophy. EClinicalMedicine 33:100742","journal-title":"EClinicalMedicine"},{"key":"355_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41436-019-0673-0","volume":"22","author":"DST Kariyawasam","year":"2020","unstructured":"Kariyawasam DST, Russell JS, Wiley V, Alexander IE, Farrar MA (2020) The implementation of newborn screening for spinal muscular atrophy: the Australian experience. Genet Med 22:557\u2013565","journal-title":"Genet Med"},{"key":"355_CR32","doi-asserted-by":"crossref","unstructured":"Kwan KM, Fujimoto E, Grabher C, Mangum BD, Hardy ME, Campbell DS, Parant JM, Yost HJ, Kanki JP, Chien CB (2007) The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev Dyn 236:3088\u20133099","DOI":"10.1002\/dvdy.21343"},{"key":"355_CR20","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1093\/hmg\/ddw044","volume":"25","author":"AS Laird","year":"2016","unstructured":"Laird AS, Mackovski N, Rinkwitz S, Becker TS, Giacomotto J (2016) Tissue-specific models of spinal muscular atrophy confirm a critical role of SMN in motor neurons from embryonic to adult stages. Hum Mol Genet 25:1728\u20131738","journal-title":"Hum Mol Genet"},{"key":"355_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, Mazzone ES, Vitale M, Snyder B, Quijano-Roy S et al (2018) Diagnosis and management of spinal muscular atrophy: Part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord 28:103\u2013115","journal-title":"Neuromuscul Disord"},{"key":"355_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3233\/JND-221577","volume":"10","author":"W Muller-Felber","year":"2023","unstructured":"Muller-Felber W, Blaschek A, Schwartz O, Glaser D, Nennstiel U, Brockow I, Wirth B, Burggraf S, Roschinger W, Becker M et al (2023) Newbornscreening SMA\u2014from pilot project to nationwide screening in Germany. J Neuromuscul Dis 10:55\u201365","journal-title":"J Neuromuscul Dis"},{"key":"355_CR23","doi-asserted-by":"publisher","first-page":"2022353","DOI":"10.1080\/20016689.2021.2022353","volume":"10","author":"M Nuijten","year":"2022","unstructured":"Nuijten M (2022) Pricing Zolgensma\u2014 the world\u2019s most expensive drug. J Mark Access Health Policy 10:2022353","journal-title":"J Mark Access Health Policy"},{"key":"355_CR24","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M et al (2020) Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol 18:e3000411","journal-title":"PLoS Biol"},{"key":"355_CR31","doi-asserted-by":"crossref","unstructured":"Punnamoottil B, Rinkwitz S, Giacomotto J, Svahn AJ, Becker TS (2015) Motor neuron-expressed microRNAs 218 and their enhancers are nested within introns of Slit2\/3 genes. Genesis 53:321\u2013328","DOI":"10.1002\/dvg.22852"},{"key":"355_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.1054573","volume":"15","author":"J Singh","year":"2022","unstructured":"Singh J, Patten SA (2022) Modeling neuromuscular diseases in zebrafish. Front Mol Neurosci 15:1054573","journal-title":"Front Mol Neurosci"},{"key":"355_CR26","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.ejpn.2018.08.009","volume":"22","author":"EF Tizzano","year":"2018","unstructured":"Tizzano EF, Zafeiriou D (2018) Prenatal aspects in spinal muscular atrophy: From early detection to early presymptomatic intervention. Eur J Paediatr Neurol 22:944\u2013950","journal-title":"Eur J Paediatr Neurol"},{"key":"355_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1221310","volume":"14","author":"A Tromp","year":"2023","unstructured":"Tromp A, Wang H, Hall TE, Mowry B, Giacomotto J (2023) Optimising the zebrafish Cre\/Lox toolbox. Codon improved iCre, new gateway tools, Cre protein and guidelines. Front Physiol 14:1221310","journal-title":"Front Physiol"},{"key":"355_CR28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.tins.2020.11.009","volume":"44","author":"B Wirth","year":"2021","unstructured":"Wirth B (2021) Spinal muscular atrophy: in the challenge lies a solution. Trends Neurosci 44:306\u2013322","journal-title":"Trends Neurosci"},{"key":"355_CR29","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1146\/annurev-genom-102319-103602","volume":"21","author":"B Wirth","year":"2020","unstructured":"Wirth B, Karakaya M, Kye MJ, Mendoza-Ferreira N (2020) Twenty-five years of spinal muscular atrophy research: from phenotype to genotype to therapy, and what comes next. Annu Rev Genomics Hum Genet 21:231\u2013261","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"355_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S1474-4422(23)00419-2","volume":"23","author":"CJJ Yeo","year":"2024","unstructured":"Yeo CJJ, Tizzano EF, Darras BT (2024) Challenges and opportunities in spinal muscular atrophy therapeutics. Lancet Neurol 23:205\u2013218","journal-title":"Lancet Neurol"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00355-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-025-00355-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00355-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:45:39Z","timestamp":1779065139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-025-00355-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,15]]}},"alternative-id":["355"],"URL":"https:\/\/doi.org\/10.1038\/s44321-025-00355-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.01.30.632288","asserted-by":"object"}]},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"28 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}